No Data
No Data
IDEAYA Biosciences Is Maintained at Buy by Goldman Sachs
IDEAYA Biosciences Is Maintained at Buy by Goldman Sachs
Express News | Goldman Sachs Maintains Buy on IDEAYA Biosciences, Lowers Price Target to $46
IDEAYA Biosciences, Inc. (NASDAQ:IDYA) Analysts Just Slashed This Year's Revenue Estimates By 28%
The analysts covering IDEAYA Biosciences, Inc. (NASDAQ:IDYA) delivered a dose of negativity to shareholders today, by making a substantial revision to their statutory forecasts for this year. This r
Analysts Are Bullish on These Healthcare Stocks: Neumora Therapeutics, Inc. (NMRA), IDEAYA Biosciences (IDYA)
Buy Rating Affirmed for IDEAYA Biosciences Amid Promising Clinical Updates and Pipeline Catalysts
Unveiling 5 Analyst Insights On IDEAYA Biosciences
In the preceding three months, 5 analysts have released ratings for IDEAYA Biosciences (NASDAQ:IDYA), presenting a wide array of perspectives from bullish to bearish.The following table encapsulates t